Wiston Quiñones

Dr. Wiston Quiñones

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2017 in Molecules
Verified
Journal Article
Open access
PDF file
EVEsteban Vargas
Esteban Vargas
FEFernando Echeverri
Fernando Echeverri
IVIván D. Vélez
Iván D. Vélez
SRSara Robledo
Sara Robledo
WQWiston Quiñones
Wiston Quiñones
The S-containing heterocyclic compounds benzothiopyrans or thiochromones stand out as having promising biological activities due to their structural relationship with chromones (benzopyrans), which are widely known as privileged scaffolds in medicinal chemistry. In this work, we report the synthesis of 35 thiochromone derivatives and the in vitro antileishmanial and cytotoxic activities. Compounds were tested against intracellular amastigotes of Leishmania panamensis and cytotoxic activity against human monocytes (U-937 ATCC CRL-1593.2). Compounds bearing a vinyl sulfone moiety, 4h, 4i, 4j, 4k, 4l and 4m, displayed the highest antileishmanial activity, with EC50 values lower than 10 μM and an index of selectivity over 100 for compounds 4j and 4l. When the double bond or the sulfone moiety was removed, the activity decreased. Our results show that thiochromones bearing a vinyl sulfone moiety are endowed with high antileishmanial activity and low cytotoxicity.

29 December 2017 in Molecules
Verified
Journal Article
Open access
PDF file
EVEsteban Vargas
Esteban Vargas
FEFernando Echeverri
Fernando Echeverri
YZYulieth Alexandra Upegui Zapata
Yulieth Alexandra Upegui Zapata
SRSara Robledo
Sara Robledo
WQWiston Quiñones
Wiston Quiñones
Cutaneous leishmaniasis (CL) is a neglected tropical disease, which causes severe skin lesions. Due to the lack of effective vaccines, and toxicity or reduced effectiveness of available drugs in addition to complex and prolonged treatments, there is an urgent need to develop alternatives for the treatment for CL with different mechanisms of action. In our effort to search for new promising hits against Leishmania parasites we prepared 18 acyl hydrazone derivatives of thiochroman-4-ones. Compounds were evaluated for their in vitro antileishmanial activity against the intracellular amastigote form of Leishmania panamensis and cytotoxic activity against human monocytes (U-937 ATCC CRL-1593.2). Our results show that derivatization of the thiochroman-4-ones with acyl hydrazones significantly enhances the antileishmanial activity. Among the compounds tested semicarbazone and thiosemicarbazone derivatives of thioflavanone 19 and 20 displayed the highest antileishmanial activities, with EC50 values of 5.4 and 5.1 µM and low cytotoxicities (100.2 and 50.1 µM respectively), resulting in higher indexes of selectivity (IS).

17 August 2020 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
LLLuis Alberto González López
Luis Alberto González López
YZYulieth Alexandra Upegui Zapata
Yulieth Alexandra Upegui Zapata
LRLuis Rivas
Luis Rivas
FEFernando Echeverri
Fernando Echeverri
GEGustavo Escobar
Gustavo Escobar
WQWiston Quiñones
Wiston Quiñones

11 February 2022 in Heliyon
Verified
Journal Article
Open access
JCJosé E. Cuellar
José E. Cuellar
WQWiston Quiñones
Wiston Quiñones
SRSara Robledo
Sara Robledo
JGjesus gil
jesus gil
DDDiego Durango
Diego Durango
Leishmaniasis, trypanosomiasis, and malaria are a group of neglected tropical diseases present in tropical regions and they affect large numbers of people in developing countries. A series of thirteen coumaro-chalcones (A1-A13) were synthesized under solvent-free conditions and their in vitro anti-leishmanial, anti-plasmodial, anti-trypanosomal and cytotoxic activities were evaluated. One of these coumaro-chalcones, 3-[(2E)-3-(3-ethoxy-4-hydroxyphenyl)prop-2-enoyl]-2H-chromen-2-one (A12), is a new compound. Compounds 3-[(2E)-3-(3-hydroxyphenyl)prop-2-enoyl]-2H-chromen-2-one (A5), 3-[(2E)-3-(3-methoxyphenyl)prop-2-enoyl]-2H-chromen-2-one (A2) and 3-[(2E)-3-phenylprop-2-enoyl]-2H-chromen-2-one (A1) displayed strong inhibition against intracellular amastigotes of Leishmania panamensis with EC50 of 2.1 ± 0.1, 2.5 ± 0.2 and 3.7 ± 0.5 μM, respectively. In addition, Plasmodium falciparum was moderately inhibited by the coumarin-chalcone hybrids, particularly A12 (EC50: 15.0 ± 0.5 μM) and 3-[(2E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]-2H-chromen-2-one (A13) (EC50: 15.2 ± 1.1 μM). Remarkably, the coumaro-chalcone A5 (EC50: 18.7 ± 2.4 μM) exhibited an inhibition of the Trypanosoma cruzi intracellular amastigotes similar to the commercial drug Benznidazole (EC50: 14.5 ± 0.1 μM). These results support the therapeutic potential of coumaro-chalcone hybrids.

14 March 2013 in Molecules
Verified
Journal Article
Open access
PDF file
APAdriana Pabon
Adriana Pabon
GEGustavo Escobar
Gustavo Escobar
EVEsteban Vargas
Esteban Vargas
VCVictor Luis Cruz
Victor Luis Cruz
RNRafael Notario
Rafael Notario
FEFernando Echeverri
Fernando Echeverri
Solanum nudum Dunal steroids have been reported as being antimalarial compounds; however, their concentration in plants is low, meaning that the species could be threatened by over-harvesting for this purpose. Swern oxidation was used for hemisynthesis of diosgenone (one of the most active steroidal sapogenin diosgenin compounds). Eighteen structural analogues were prepared; three of them were found to be more active than diosgenone (IC50 27.9 μM vs. 10.1 μM, 2.9 μM and 11.3 μM). The presence of a 4-en-3-one grouping in the A-ring of the compounds seems to be indispensable for antiplasmodial activity; progesterone (having the same functional group in the steroid A-ring) has also displayed antiplasmodial activity. Quantitative correlations between molecular structure and bioactivity were thus explored in diosgenone and several derivatives using well-established 3D-QSAR techniques. The models showed that combining electrostatic (70%) and steric (30%) fields can explain most variance regarding compound activity. Malarial parasitemia in mice became reduced by oral administration of two diosgenone derivatives.

12 February 2020 in Molecules
Verified
Journal Article
Open access
PDF file
COCristian Ortiz
Cristian Ortiz
FEFernando Echeverri
Fernando Echeverri
SRSara Robledo
Sara Robledo
Daniela LanariDaniela Lanari
Daniela Lanari
MCMassimo Curini
Massimo Curini
EVEsteban Vargas
Esteban Vargas
In continuation of our efforts to identify promising antileishmanial agents based on the chroman scaffold, we synthesized several substituted 2H-thiochroman derivatives, including thiochromenes, thichromanones and hydrazones substituted in C-2 or C-3 with carbonyl or carboxyl groups. Thirty-two compounds were thus obtained, characterized, and evaluated against intracellular amastigotes of Leishmania (V) panamensis. Twelve compounds were active, with EC50 values lower than 40 µM, but only four compounds displayed the highest antileishmanial activity, with EC50 values below 10 µM; these all compounds possess a good Selectivity Index > 2.6. Although two active compounds were thiochromenes, a clear structure-activity relationship was not detected since each active compound has a different substitution pattern.